Humoral and cellular immune responses against Type I cysteine proteinase of Leishmania infantum are higher in asymptomatic than symptomatic dogs selected from a naturally infected population

Veterinary Parasitology

Volumn 119, Issue 2-3, 2004, Pages 107-123

  Nakhaee, Alireza ^a   Taheri, Tahere ^b   Taghikhani, Mohammad ^a,b   Mohebali, Mehdi ^c   Salmanian, Ali Hatef ^d   Fasel, Nicolas ^e   Rafati, Sima ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^e UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

C terminal extension; Cysteine proteinases; Dog; Immunity; Leishmania infantum

Indexed keywords

ANTIGEN; CYSTEINE PROTEINASE; IMMUNOGLOBULIN ANTIBODY; ISOENZYME; PAPAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LYSATE; CELLULAR IMMUNITY; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOG DISEASE; FREEZING; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOREACTIVITY; LEISHMANIA DONOVANI; LEISHMANIASIS; MOLECULE; MONONUCLEAR CELL; NONHUMAN; PARASITOSIS; POPULATION; THAWING;

CANIS FAMILIARIS; LEISHMANIA INFANTUM; PROTOZOA;

EID: 1642472963     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2003.11.013     Document Type: Article

References (60)

1. Abranches P., Santos-Gomes G., Rachamim N., Campino L., Schnur L., Jaffe C.L. An experimental model for canine visceral leishmaniasis. Parasite Immunol. 13:1991;537-550.
2. Abranches P., Silva-Pereira M.C., Conceicao-Silva F.M., Santos-Gomes G.M., Janz J.G. Canine leishmaniasis: pathology and ecological factors influencing transmission of infection. J. Parasitol. 77:1991;557-561.
3. Acedo-Sanchez C., Morillas-Marquez F., Sanchiz-Marin M.C., Martin-Sanchez J. Changes in antibody titres against Leishmania infantum in naturally infected dogs in southern Spain. Vet. Parasitol. 75:1998;1-8.
4. Bettini S., Gradoni L. Canine leishmaniasis in the Mediterranean area and its implications for human leishmaniasis. Insect Sci. Appl. 7:1986;241-245.
5. Cabral M., O'Grady J.E., Alexander J. Demonstration of Leishmania specific cell mediated and humoral immunity in asymptomatic dogs. Parasite Immunol. 14:1992;531-539.
6. Cabral M., O'Grady J.E., Gomes S., Sousa J.C., Thompson H., Alexander J. The immunology of canine leishmaniasis: strong evidence for a developing disease spectrum from asymptomatic dogs. Vet. Parasitol. 76:1998;173-180.
7. Campos-Neto A., Soong L., Cordova J.L., Sant'Angelo D., Skeiky Y.A.W., Ruddle N.H., Reed S.G., Janeway C., McMahon-Pratt D. Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages. J. Exp. Med. 182:1995;1423-1433.
8. Carrera L., Fermin M.L., Tesouro M., Gracia P., Rollan E., Gonzalez J.L., Mendez S., Cuquerella M., Alunda J.M. Antibody response in dogs experimentally infected with Leishmania infantum: infection course antigen markers. Exp. Parasitol. 82:1996;139-146.
9. Connell N.D., Medina-Acosta E., McMaster W.R., Bloom B.R., Russell D. Effective immunization against cutaneous leishmaniasis with recombinant Bacilli Calmette Guerin expressing the Leishmania surface protein gp63. Proc. Natl. Acad. Sci. 90:1993;1147-11473.
10. Coombs G.H. Proteinases of Leishmania mexicana and other flagellate protozoa. Parasitology. 84:1982;149-155.
11. Coombs G.H., Mottram J.C. Parasite proteinases and amino acid metabolism: possibility for chemotherapeutic exploitation. Parasitology. 114:1997;S61-S80.
12. Deplazes P., Smith N.C., Arnold P., Lutz H., Eckert J. Specific IgG1 and IgG2 antibody response of dogs to Leishmania infantum and other parasites. Parasite Immunol. 17:1995;451-458.
13. Dye C. The logic of visceral leishmaniasis control. Am. J. Trop. Med. Hyg. 55:1996;125-130.
14. Edrissian G.H. Kala-azar in Iran. Med. J. Isla. Rep. Iran. 4:1990;235-238.
15. Gicheru M.M., Olobo J.O., Kariuki T.M., Adhiambo C. Visceral leishmanisis in vervet monkeys: immunological responses during asymptomatic infection. Scand. J. Immunol. 41:1995;202-208.
16. Guerin P.J., Olliaro P., Sundar S., Boelaert M., Croft S., Desjeux P., Wasunna M.K., Bryceson A.D.M. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet. 22:2002;494-501.
17. Kawano Y., Noma T., Yata J. Regulation of human IgG subclass production by cytokines IFN-γ and IL-6 act antagonistically in the induction of human IgG1 but additively in induction of IgG2. J. Immunol. 153:1994;4948-4958.
18. Leandro C., Santos-Gomes G.M., Campino L., Romao P., Cortes S., Rolao N., Gomes-Pereira S., Rica Capela M.J., Abranches P. Cell-mediated immunity and specific IgG1 and IgG2 antibody response in natural and experimental canine leishmaniosis. Vet. Immunol. Immunopathol. 79:2001;273-284.
19. Luna R.D., Vuotto M.L., Ielpo M.T.L., Ambrosio R., Piantedosi D., Moscatiello V., Ciaramella P., Scalone A., Gradoni L., Mancino D. Early suppression of lymphoproliferative response in dogs with natural infection by Leishmania infantum. Vet. Immunol. Immunopathol. 70:1999;95-103.
20. Masina S., Gicheru M., Demotz S., Fasel N. Protection against cuteneous leishmaniasis in outbred vervet monkeys with a recombinant H1 antigen. J. Infect. Disease. 188:2003;1250-1257.
21. Mazloumi A.S., Hodjati M.H., Mohite H., Davies C.R. Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial. Lancet. 360:2002;374-379.
22. McKerrow J.H., Engel J.C., Caffrey C.R. Cysteine protease inhibitors as chemotherapy for parasite infections. Bioorg. Med. Chem. 7:1999;639-644.
23. McMahon-Pratt D., Rodriguez J.R., Zhang Y., Manson K., Bergman C., Rivas L., Rodriguez J.F., Lohman K.L. Recombinant vaccina viruses expressing GP46/M2 protect against Leishmania infection. Infect. Immun. 61:1993;3351-3359.
24. Melby P.C., Yang J., Zhao W., Perez L., Cheng J. Leishmania donovani p36 (LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis. Infect. Immun. 69:2001;4719-4725.
25. Miralles G.D., Stoeckle M.Y., McDermott D.F., Finkelman F.D., Murray H.W. Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infect. Immun. 62:1994;1058-1063.
26. Moreno J., Alvar J. Canine leishmaniasis: epidemiological risk and experimental model. Trends Parasitol. 18:2002;399-405.
27. Mottram J.C., Brooks D.R., Coombs G.H. Role of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions. Curr. Opin. Microbiol. 1:1998;455-460.
28. Mottram J.C., Helms M.J., Coombs G.H., Sajid M. Clan CD cysteine peptidases of parasitic protozoa. Trends Parasitol. 19:2003;182-187.
29. Mottram J.C., Robertson C.D., Coombs G.H., Barry J.D. A developmentally regulated cysteine proteinase gene of Leishmania mexicana. Mol. Microbiol. 6:1992;1925-1932.
30. Mottram J.C., North M.J., Barry J.D., Coombs G.H. A cysteine proteinase cDNA from Trypanosoma brucei predicts an enzyme with an unusual C-terminal extension. FEBS Lett. 258:1989;211-215.
31. Nadim A. Present status of kala-azar in Iran. Am. J. Trop. Med. Hyg. 27:1978;25-28.
32. Nieto C.G., Garcia-Alanso M., Requena J.M., Mirom C., Soto M., Alonso C., Navarrete I. Analysis of humoral immune response against total and recombinant antigens of Leishmania infantum: correlation with disease progression in canine experimental leishmaniasis. Vet. Immunol. Immunopathol. 67:1999;11-130.
33. Ortiz M.L., Calero M., Patron C.F., Castellanos L., Mendez E. Imidazole-SDS-Zn reverse staining of proteins in gels containing or not SDS and microsequencing of individual unmodified electroblotted proteins. FEBS Lett. 296:1992;300-304.
34. Pascalis H., Lavergen A., Bourrea E., Prevost-Linguet G., Kariminia A., Pradinaud R., Rafati S., Launois P. Th1 cell development induced by cysteine proteinases A and B in localized cutaneous leishmaniasis due to Leishmania guyanensis. Infect. Immun. 71:2003;2924-2926.
35. Pinelli E., Killick-Kendrick R., Wagenhaar J., Bernadina W., del Real G., Ruitenberg J. Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum. Infect. Immun. 62:1994;229-235.
36. Pupkis M., Tetely L., Coombs G. Leishmania mexicana: amastigote hydrolases in unusual lysosome. Exp. Parasitol. 62:1986;29-39.
37. + T lymphocyte activation. Vaccine. 20:2002;2439-2447.
38. Rafati S., Couty-Jouve S., Alimohammadian M.H., Louis J.A. Biochemical analysis and immunogenicity of Leishmania major amastigote fractions in cutaneous leishmaniasis. Clin. Exp. Immunol. 110:1997;203-211.
39. Rafati S., Abraham-Baba A., Bakhshayesh M., Vafa M. Vaccination of BALB/ c mice with Leishmania major amastigote-specific cysteine proteinase. Clin. Exp. Immunol. 120:2000;134-138.
40. Rafati S., Salmanian A., Hashemi K., Schaff C., Belli S., Fasel N. Identification of Leishmania major cysteine proteinases as targets of the immune response in human. Mol. Biochem. Parasitol. 113:2001;35-43.
41. Rafati S., Fasel N., Masina S. Leishmania cysteine proteinases: from gene to subunit vaccine. Curr. Genom. 4:2003;109-121.
42. Rafati S., Nakahaee A., Tahere T., Ghashghaii A., Salmanian A.H., Jimenez M., Mohebali M., Masina S., Fasel N. Expression of cysteine proteinase Type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis. Exp. Parasitol. 103:2003;143-151.
43. Reed S., Scott P. T-cell cytokine response in leishmaniasis. Curr. Opin. Immunol. 5:1993;524-531.
44. Rhalem A., Sahibi H., Guessous-Idrissi N., Lasri S., Natami A., Riyad M., Berrag B. Immune response against Leishmania antigens in dogs naturally and experimentally infected with Leishmania infantum. Vet. Parasitol. 81:1999;173-184.
45. Robertson, C.D., Coombs, G.H., North, M.J., Mottram, J.C., 1996. Parasite cysteine proteinases. In: McKerrow, J.H., James, M.N.G. (Eds.), Perspective in Drug Discovery and Design, vol. 6. ESCOM Science Publisher BV, pp. 99-118.
46. Roggero M.A., Servis C., Corradin G. A simple and rapid procedure for the purification of synthetic polypeptides by a combination of affinity chromatography and methionine chemistry. FEBS Lett. 408:1997;285-288.
47. Sacks D.L., Lal L.S., Shrivastava S.N., Blackwell J., Neva F.A. An analysis of T-cell responsiveness in Indian kala-azar. J. Immunol. 138:1987;908-913.
48. Sajid M., McKerrow J.H. Cysteine proteinases of parasitic organisms. Mol. Biochem. Parasitol. 120:2002;1-21.
49. Santos-Gomes G.M., Rosa R., Leandro C., Cortes S., Romao P., Silveira H. Cytokine expression during the outcome of canine experimental infection by Leishmania infantum. Vet. Immunol. Immunopathol. 88:2002;21-30.
50. Selzer P.M., Pingel S., Hsieh I., Ugele B., Chan V.J., Engel J.C., Bogyo M., Russell D.G., Sakanari J.A., McKerrow J.H. Cysteine protease inhibitors as chemotherapy: lessons from a parasite target. Proc. Natl. Acad. Sci. U.S.A. 96:1999;11015-11022.
51. Sjolander A., Baldwin T.M., Curtis J.M., Handman E. Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis. J. Immunol. 160:1998;3949-3957.
52. Skeiky Y.A.W., Benson D.R., Guderian J.A., Whittle J.A., Bacelar O., Carvalho E.M., Reed S.G. Immune responses of leishmaniasis patients to heat shock proteins of Leishmania species and humans. Infect. Immun. 63:1995;4105-4114.
53. Skeiky Y.A.W., Kennedy M., Kaufaman D., Borges M.M., Guderian J.A., Scholler J.K., Ovendale P.J., Picha K.S., Morrissey P.J., Grabstein K.H., Campos-Neto A., Reed S.G. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile. J. Immunol. 161:1998;6171-6179.
54. Solioz N., Blum-Tirouvanziam U., Jacqute R., Rafati S., Corradin G., Mauel J., Fasel N. The protective capacities of histone H1 against experimental murine cutaneous leishmaniasis. Vaccine. 18:1999;850-859.
55. Souza A., Waugh S., Coombs G.H., Mottram J.C. Characterization of a multi-copy gene for a major stage-specific cysteine proteinase of Leishmania mexicana. FEBS Lett. 311:1992;124-127.
56. Tesh R.B. Control of zoonotic visceral leishmaniasis: is it time to changes strategies? Am. J. Trop. Med. Hyg. 52:1995;287-292.
57. Traub-Cseko Y.M., Duboise M., Boukai L.K., McMahon-pratt D. Identification of two distinct cysteine proteinase genes of Leishmania pifanoi axenic amastigotes using the polymerase chain reaction. Mol. Biochem. Parasitol. 57:1993;101-116.
58. Web J.R., Campos-Neto A., Ovendale P.J., Martin T.I., Stromberg E.J., Badaro R., Reed S.G. Human and murine immune responses to a novel L. major recombinant protein encoded by members of a multicopy gene family. Infect. Immun. 66:1998;3279-3289.
59. Web J.R., Kaufman D., Campos-Neto A., Reed S.G. Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis. J. Immunol. 157:1996;5034-5041.
60. Wilson M.E., Young B.M., Andersen K.P., Weinstock J.V., Metwali K.M., Donelson J.E. A recombinant Leishmania chagasi antigen that stimulates cellular immune responses in infected mice. Infect. Immun. 63:1995;2062-2069.